Teradyne, Inc. (NYSE: TER) reported revenue of $170 million for the
second quarter of 2009. Semiconductor Test revenue totaled $103 million
and Systems Test Group revenue totaled $67 million, which included
initial Hard Disk Drive test system revenues. On a non-GAAP basis,
Teradyne’s net loss in the second quarter was $35.6 million, or $0.21
per diluted share, which excluded restructuring charges, acquired
intangible asset amortization and special items. The GAAP net loss for
the second quarter was $66.8 million, or $0.39 per diluted share.
The second quarter revenue of $170 million was $40 million above the
high end of guidance while the non-GAAP net loss per share of $0.21 was
slightly better than the guidance of $0.26 to $0.23. The higher revenue
did not result in a smaller net loss per share due to the previously
disclosed zero gross margin on the initial Hard Disk Drive test system
shipments and due to inventory charges incurred in the quarter.
Bookings in the second quarter of 2009 were $227 million. Semiconductor
Test orders were $138 million and Systems Test Group orders were $89
million, which included additional Hard Disk Drive test system orders.
Guidance for the third quarter of 2009 is for revenue of $190 million to
$205 million, with a Non-GAAP net loss per share of $0.02 to net income
per share of $0.02 and a GAAP net loss per share between $0.13 and
$0.09. Non-GAAP guidance excludes restructuring charges, acquired
intangible asset amortization and special items.
"We saw significant improvement in our System-On-Chip (SOC) test
business in the second quarter from the trough in orders in Q1,” said
Mike Bradley, Teradyne president and CEO. "In SOC, bookings in the
quarter were driven by improving demand in wireless and analog/power
management from both integrated device manufacturers (IDMs) and
outsourced semiconductor assembly and test (OSAT) customers. In our Hard
Disk Drive test business, customer acceptance for the majority of our
initial shipments accelerated and our lead customer placed a second
round of orders. We’re ramping the supply chain to meet the increased
demand in SOC and Hard Disk Drive at the same time that we hold the line
on costs.”
Webcast
A webcast to discuss second quarter 2009 results, along with
management's business outlook will be held at 10 a.m. EDT, Thursday,
July 30, 2009. Interested investors should access the webcast at www.teradyne.com
and click on "Investors" at least five minutes before the call begins.
The webcast replay will be available on www.teradyne.com.
In addition, a conference call replay will be available approximately
two hours after the call. The replay number in the U.S. & Canada is
800-642-1687. The replay number outside the U.S. & Canada is
706-645-9291. The pass code for both numbers is 20503616.
The
replay will be available via phone and web site through August 13, 2009.
Non-GAAP Results
In addition to disclosing results that are determined in accordance with
GAAP, Teradyne also discloses non-GAAP results of operations that
exclude certain income items and charges. These results are provided as
a complement to results provided in accordance with GAAP. Teradyne
reports non-GAAP results in order to better assess and reflect operating
performance. Management believes the non-GAAP measures help indicate
Teradyne's baseline performance before gains, losses or other charges
that may not be indicative of our current core business or future
outlook. Teradyne believes these non-GAAP measures will aid investors'
overall understanding of its results by providing a higher degree of
transparency for certain expenses and providing a level of disclosure
that will help investors understand how Teradyne plans and measures its
own business. A reconciliation of each available GAAP to non-GAAP
financial measure discussed in this press release is contained in the
attached exhibits and on the Teradyne website at www.teradyne.com
by clicking on "Investors" and then selecting the "GAAP to Non-GAAP
Reconciliation" link. The presentation of non-GAAP measures is not meant
to be considered in isolation, as a substitute for, or superior to,
financial measures or information provided in accordance with GAAP.
About Teradyne, Inc.
Teradyne (NYSE: TER) is a leading supplier of Automatic Test Equipment
used to test complex electronics used in the consumer electronics,
automotive, computing, telecommunications, and aerospace and defense
industries. In 2008, Teradyne had sales of $1.1 billion. For more
information, visit www.teradyne.com.
Teradyne(R) is a registered trademark of Teradyne, Inc. in
the U.S. and other countries. All product names are trademarks of
Teradyne, Inc. (including its subsidiaries) or their respective owners.
Safe Harbor Statement
The forward-looking statements included in this release are made only as
of the date of publication. Teradyne disclaims any intention or
obligation to update any forward-looking statements as a result of
developments occurring after the date of this press release.
This release contains forward-looking statements regarding future
business prospects, our results of operations and market conditions.
Such statements are based on the current assumptions and expectations of
Teradyne’s management and are neither promises nor guarantees of future
performance. You can identify these forward-looking statements based on
the context of the statements and by the fact that they use words such
as "will,” "anticipate,” "expect,” "project,” "intend,” "plan,”
"believe,” "target” and other words and terms of similar meaning in
connection with any discussion of future operating or financial
performance. There can be no assurance that management’s estimates of
our future results or other forward looking statements will be achieved.
Important factors that could cause actual results to differ materially
from those presently expected include: conditions affecting the markets
in which Teradyne operates, including a continued or further
deterioration of the semiconductor equipment market; decreased product
demand; delays in new product introductions; lack of customer acceptance
of new products; unanticipated delays in or costs and expenses relating
to the implementation of cost reduction plans; and other events, factors
and risks disclosed in filings with the SEC, including, but not limited
to, the "Risk Factors” section of Teradyne’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2008 and Quarterly Report on Form
10-Q for the period ended April 5, 2009.
|
|
|
TERADYNE, INC. REPORT FOR SECOND FISCAL QUARTER OF 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONDENSED CONSOLIDATED OPERATING STATEMENTS
|
|
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended:
|
|
|
Six Months Ended:
|
|
|
|
|
|
July 5, 2009
|
|
|
April 5, 2009
|
|
|
June 29, 2008
|
|
|
July 5, 2009
|
|
|
June 29, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues (1)
|
|
|
$
|
169,580
|
|
|
|
$
|
120,608
|
|
|
|
$
|
317,705
|
|
|
|
$
|
290,188
|
|
|
|
$
|
615,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Revenues (2) (3) (4)
|
|
|
|
122,451
|
|
|
|
|
87,248
|
|
|
|
|
163,857
|
|
|
|
|
209,699
|
|
|
|
|
322,669
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
|
47,129
|
|
|
|
|
33,360
|
|
|
|
|
153,848
|
|
|
|
|
80,489
|
|
|
|
|
292,351
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Engineering and Development
|
|
|
|
38,451
|
|
|
|
|
47,198
|
|
|
|
|
56,154
|
|
|
|
|
85,649
|
|
|
|
|
111,303
|
|
|
Selling and Administrative
|
|
|
|
47,257
|
|
|
|
|
55,373
|
|
|
|
|
65,463
|
|
|
|
|
102,630
|
|
|
|
|
130,684
|
|
|
Acquired Intangible Asset Amortization
|
|
|
|
8,214
|
|
|
|
|
8,239
|
|
|
|
|
4,774
|
|
|
|
|
16,453
|
|
|
|
|
8,637
|
|
|
In-process Research and Development
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
1,100
|
|
|
Restructuring and Other, net (5)
|
|
|
|
15,270
|
|
|
|
|
15,965
|
|
|
|
|
12,726
|
|
|
|
|
31,235
|
|
|
|
|
24,511
|
|
|
|
Operating Expenses
|
|
|
|
109,192
|
|
|
|
|
126,775
|
|
|
|
|
139,117
|
|
|
|
|
235,967
|
|
|
|
|
276,235
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/Income from Operations
|
|
|
|
(62,063
|
)
|
|
|
|
(93,415
|
)
|
|
|
|
14,731
|
|
|
|
|
(155,478
|
)
|
|
|
|
16,116
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest & Other (6)
|
|
|
|
(6,905
|
)
|
|
|
|
(5,053
|
)
|
|
|
|
2,448
|
|
|
|
|
(11,958
|
)
|
|
|
|
7,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/Income Before Income Taxes
|
|
|
|
(68,968
|
)
|
|
|
|
(98,468
|
)
|
|
|
|
17,179
|
|
|
|
|
(167,436
|
)
|
|
|
|
23,646
|
|
|
Income Tax (Benefit)/Provision
|
|
|
|
(2,200
|
)
|
|
|
|
(7,800
|
)
|
|
|
|
6,100
|
|
|
|
|
(10,000
|
)
|
|
|
|
10,200
|
|
|
Net (Loss)/Income
|
|
|
|
(66,768
|
)
|
|
|
|
(90,668
|
)
|
|
|
|
11,079
|
|
|
|
|
(157,436
|
)
|
|
|
|
13,446
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss)/Income per Common Share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
(0.39
|
)
|
|
|
$
|
(0.53
|
)
|
|
|
$
|
0.06
|
|
|
|
$
|
(0.91
|
)
|
|
|
$
|
0.08
|
|
|
Diluted
|
|
|
$
|
(0.39
|
)
|
|
|
$
|
(0.53
|
)
|
|
|
$
|
0.06
|
|
|
|
$
|
(0.91
|
)
|
|
|
$
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Common Shares - Basic
|
|
|
|
173,022
|
|
|
|
|
172,130
|
|
|
|
|
170,644
|
|
|
|
|
172,576
|
|
|
|
|
172,203
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Common Shares - Diluted
|
|
|
|
173,022
|
|
|
|
|
172,130
|
|
|
|
|
174,096
|
|
|
|
|
172,576
|
|
|
|
|
174,909
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Orders
|
|
|
$
|
227,331
|
|
|
|
$
|
136,346
|
|
|
|
$
|
307,940
|
|
|
|
$
|
363,677
|
|
|
|
$
|
628,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) For the quarter and six months ended July 5, 2009, Net Revenues
and Cost of Revenues included $26 million for Hard Disk Drive test
systems.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) For the quarters ended July 5, 2009 and April 5, 2009, Cost of
Revenues included an added cost of $3.9 million and $1.2 million,
respectively, for inventory step-up as a result of purchase
accounting. For the six months ended July 5, 2009 and June 29, 2008,
Cost of Revenues included an added cost of $5.1 million and $4.3
million, respectively, for inventory step-up as a result of purchase
accounting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) For the quarter and six months ended July 5, 2009, Cost of
Revenues included a credit of $1.0 million related to an insurance
recovery. For the six months ended June 29, 2008, Cost of Revenues
included a credit of $0.9 million related to previously written down
inventory in the Semiconductor Test Division.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4) For the quarters ended July 5, 2009, April 5, 2009, and June 29,
2008, Cost of Revenues included a provision for excess and obsolete
inventory of $11.5 million, $8.6 million and $1.9 million,
respectively. For the six months ended July 5, 2009 and June 29,
2008, Cost of Revenues included a provision for excess and obsolete
inventory of $20.1 million and $3.3 million, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5) Restructuring and other, net consists of:
|
|
|
Quarter Ended:
|
|
|
Six Months Ended:
|
|
|
|
|
|
July 5, 2009
|
|
|
April 5, 2009
|
|
|
June 29, 2008
|
|
|
July 5, 2009
|
|
|
June 29, 2008
|
|
|
Employee Severance
|
|
|
$
|
14,976
|
|
|
|
$
|
16,678
|
|
|
|
$
|
5,510
|
|
|
|
$
|
31,654
|
|
|
|
$
|
12,623
|
|
|
|
Eagle Test Purchase Accounting Adjustment
|
|
|
|
(774
|
)
|
|
|
|
(713
|
)
|
|
|
|
-
|
|
|
|
|
(1,487
|
)
|
|
|
|
-
|
|
|
|
Facility Related
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
8,348
|
|
|
|
|
-
|
|
|
|
|
13,020
|
|
|
|
Long-Lived Asset Impairment
|
|
|
|
1,068
|
|
|
|
|
-
|
|
|
|
|
550
|
|
|
|
|
1,068
|
|
|
|
|
550
|
|
|
|
(Gain)/Loss on Sale of Real Estate
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
(1,682
|
)
|
|
|
|
-
|
|
|
|
|
(1,682
|
)
|
|
|
|
|
|
$
|
15,270
|
|
|
|
$
|
15,965
|
|
|
|
$
|
12,726
|
|
|
|
$
|
31,235
|
|
|
|
$
|
24,511
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6) For the quarter and six months ended July 5, 2009, Interest and
Other included a charge of $2.5 million to expense deferred debt
financing costs as a result of the repayment and termination of
Teradyne's revolving line of credit. For the quarter and six months
ended July 5, 2009, Interest and Other included amortization of $2.3
million for the GAAP imputed convertible debt discount. For the
quarter ended April 5, 2009 and six months ended July 5, 2009,
Interest and Other included a charge of $2.6 million for
other-than-temporary impairment and realized losses on marketable
securities.
|
|
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)
|
|
|
|
|
|
|
July 5, 2009
|
|
|
December 31, 2008
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents
|
|
|
|
$
|
334,081
|
|
|
$
|
322,705
|
|
Accounts Receivable
|
|
|
|
|
73,914
|
|
|
|
109,625
|
|
Inventories (1)
|
|
|
|
|
126,689
|
|
|
|
168,451
|
|
Deferred Tax Assets
|
|
|
|
|
17,268
|
|
|
|
16,988
|
|
Prepayments and Other Current Assets
|
|
|
|
51,781
|
|
|
|
60,884
|
|
|
|
|
|
|
|
603,733
|
|
|
|
678,653
|
|
|
|
|
|
|
|
|
|
|
|
Net Property, Plant and Equipment
|
|
|
|
270,369
|
|
|
|
298,449
|
|
Long-Term Marketable Securities
|
|
|
|
|
38,982
|
|
|
|
51,613
|
|
Intangible Assets
|
|
|
|
|
170,545
|
|
|
|
186,998
|
|
Other Assets
|
|
|
|
|
18,751
|
|
|
|
19,534
|
|
|
|
|
|
|
$
|
1,102,380
|
|
|
$
|
1,235,247
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
Accounts Payable
|
|
|
|
|
47,979
|
|
|
|
61,164
|
|
Current Debt (2)
|
|
|
|
|
2,069
|
|
|
|
122,500
|
|
Accrued Employees' Compensation and Withholdings
|
|
|
54,708
|
|
|
|
73,521
|
|
Deferred Revenue and Customer Advances
|
|
|
|
49,730
|
|
|
|
58,030
|
|
Other Accrued Liabilities
|
|
|
|
|
42,590
|
|
|
|
51,748
|
|
|
|
|
|
|
|
197,076
|
|
|
|
366,963
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Plans Liabilities
|
|
|
|
|
133,478
|
|
|
|
125,877
|
|
Deferred Tax Liabilities
|
|
|
|
|
3,158
|
|
|
|
8,730
|
|
Other Long-Term Liabilities
|
|
|
|
|
22,965
|
|
|
|
27,565
|
|
Long-Term Debt (2) (3)
|
|
|
|
|
137,087
|
|
|
|
-
|
|
|
|
|
|
|
|
493,764
|
|
|
|
529,135
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Equity
|
|
|
|
|
608,616
|
|
|
|
706,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,102,380
|
|
|
$
|
1,235,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) As of July 5, 2009 and December 31, 2008, Inventories include
approximately $10 million and $15 million, respectively, for Eagle
Test inventory fair value step-up.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) On March 31, 2009, we entered into a loan agreement in Japan for
approximately $10 million. The loan has a term of 5 years and a
fixed interest rate of 1.4%. At July 5, 2009, $2 million of the
outstanding loan principal is included in current debt and $8
million is classified as long-term debt.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) On March 31, 2009, in connection with our convertible note
offering, we entered into convertible note hedge and warrant
transactions. These transactions are expected to reduce the
potential dilution to Teradyne's common stock upon maturity of the
convertible notes. On April 6, 2009, the convertible note and
convertible note hedge and warrant transactions closed and we
netted approximately $163 million of cash, before paying off the
$122.5 million bank revolver. For information on possible dilution
related to the convertible note, investors should access
Teradyne's website at www.teradyne.com
and click on "Investors" and then select the "Financial Data" link.
|
|
|
|
|
|
|
|
GAAP to Non-GAAP Earnings Reconciliation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References by the Company to non-GAAP (loss)/income and non-GAAP
(loss)/income per share refer to net (loss)/income and net
(loss)/income per common share excluding goodwill impairment,
in-process research and development, amortization of the GAAP
imputed convertible debt discount, write-off of credit line debt
issue costs, restructuring and other, net, certain inventory
provision reversals, fair value inventory step-up related to Nextest
and Eagle Test, losses on marketable securities and acquired
intangible asset amortization, as well as applicable adjustments to
profit sharing and income taxes due to these exclusions. GAAP
requires that these items be included in determining net
(loss)/income. Non-GAAP (loss)/income (which is the basis for
non-GAAP (loss)/income per share) gives an indication of Teradyne's
baseline performance before gains, losses or other charges that may
not be indicative of our current core business or future outlook.
|
|
|
|
|
|
|
|
|
|
|
|
The Company believes these non-GAAP measures will aid investors'
overall understanding of the Company's results by providing a higher
degree of transparency for certain expenses and providing a level of
disclosure that will help investors understand how the Company plans
and measures its own business. However, the presentation of non-GAAP
measures is not meant to be considered in isolation or as a
substitute for, or superior to, financial information provided in
accordance with GAAP.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended:
|
|
|
|
|
|
Six Months Ended:
|
|
|
|
|
|
|
|
July 5, 2009
|
|
|
|
April 5, 2009
|
|
|
June 29, 2008
|
|
|
|
|
|
July 5, 2009
|
|
|
|
|
June 29, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues
|
|
|
$
|
169.6
|
|
|
|
|
$
|
120.6
|
|
|
|
$
|
317.7
|
|
|
|
|
|
|
$
|
290.2
|
|
|
|
|
|
$
|
615.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Margin - GAAP
|
|
$
|
47.1
|
|
|
27.8
|
%
|
|
$
|
33.4
|
|
27.7
|
%
|
|
$
|
153.8
|
|
|
48.4
|
%
|
|
|
|
$
|
80.5
|
|
|
27.7
|
%
|
|
|
$
|
292.4
|
|
|
47.5
|
%
|
|
Inventory step-up reversal (1)
|
|
|
3.9
|
|
|
|
|
|
1.2
|
|
|
|
|
-
|
|
|
|
|
|
|
|
5.1
|
|
|
|
|
|
|
4.3
|
|
|
|
|
Insurance recovery
|
|
|
(1.0
|
)
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(1.0
|
)
|
|
|
|
|
|
-
|
|
|
|
|
Inventory provision reversal (2)
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
(0.9
|
)
|
|
|
|
Gross Margin - non-GAAP
|
|
$
|
50.0
|
|
|
29.5
|
%
|
|
$
|
34.6
|
|
28.7
|
%
|
|
$
|
153.8
|
|
|
48.4
|
%
|
|
|
|
$
|
84.6
|
|
|
29.2
|
%
|
|
|
$
|
295.8
|
|
|
48.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss)/Income from Operations - GAAP
|
|
$
|
(62.1
|
)
|
|
-36.6
|
%
|
|
$
|
(93.4
|
)
|
-77.4
|
%
|
|
$
|
14.7
|
|
|
4.6
|
%
|
|
|
|
$
|
(155.5
|
)
|
|
-53.6
|
%
|
|
|
$
|
16.1
|
|
|
2.6
|
%
|
|
Restructuring and other, net (3)
|
|
|
15.3
|
|
|
|
|
|
16.0
|
|
|
|
|
12.7
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
24.5
|
|
|
|
|
Acquired intangible asset amortization
|
|
|
8.2
|
|
|
|
|
|
8.2
|
|
|
|
|
4.8
|
|
|
|
|
|
|
|
16.5
|
|
|
|
|
|
|
8.6
|
|
|
|
|
Inventory step-up reversal (1)
|
|
|
3.9
|
|
|
|
|
|
1.2
|
|
|
|
|
-
|
|
|
|
|
|
|
|
5.1
|
|
|
|
|
|
|
4.3
|
|
|
|
|
Insurance recovery
|
|
|
(1.0
|
)
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(1.0
|
)
|
|
|
|
|
|
-
|
|
|
|
|
In-process research and development
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
1.1
|
|
|
|
|
Inventory provision reversal (2)
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
(0.9
|
)
|
|
|
|
Profit sharing adjustment (5)
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
(0.7
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
(1.5
|
)
|
|
|
|
(Loss)/Income from Operations - non-GAAP
|
|
$
|
(35.7
|
)
|
|
-21.0
|
%
|
|
$
|
(68.0
|
)
|
-56.4
|
%
|
|
$
|
31.5
|
|
|
9.9
|
%
|
|
|
|
$
|
(103.7
|
)
|
|
-35.7
|
%
|
|
|
$
|
52.2
|
|
|
8.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss)/Income - GAAP
|
|
$
|
(66.8
|
)
|
|
-39.4
|
%
|
|
$
|
(90.7
|
)
|
-75.2
|
%
|
|
$
|
11.1
|
|
|
3.5
|
%
|
|
|
|
$
|
(157.4
|
)
|
|
-54.2
|
%
|
|
|
$
|
13.4
|
|
|
2.2
|
%
|
|
Restructuring and other, net (3)
|
|
|
15.3
|
|
|
|
|
|
16.0
|
|
|
|
|
12.7
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
24.5
|
|
|
|
|
Acquired intangible asset amortization
|
|
|
8.2
|
|
|
|
|
|
8.2
|
|
|
|
|
4.8
|
|
|
|
|
|
|
|
16.5
|
|
|
|
|
|
|
8.6
|
|
|
|
|
Interest and other (4)
|
|
|
4.8
|
|
|
|
|
|
2.6
|
|
|
|
|
-
|
|
|
|
|
|
|
|
7.4
|
|
|
|
|
|
|
-
|
|
|
|
|
Inventory step-up reversal (1)
|
|
|
3.9
|
|
|
|
|
|
1.2
|
|
|
|
|
-
|
|
|
|
|
|
|
|
5.1
|
|
|
|
|
|
|
4.3
|
|
|
|
|
Insurance recovery
|
|
|
(1.0
|
)
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
(1.0
|
)
|
|
|
|
|
|
-
|
|
|
|
|
In-process research and development
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
1.1
|
|
|
|
|
Inventory provision reversal (2)
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
(0.9
|
)
|
|
|
|
Profit sharing adjustment (5)
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
(0.7
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
(1.5
|
)
|
|
|
|
Income tax adjustment (6)
|
|
|
-
|
|
|
|
|
|
(2.9
|
)
|
|
|
|
0.2
|
|
|
|
|
|
|
|
(2.9
|
)
|
|
|
|
|
|
0.2
|
|
|
|
|
Net (Loss)/Income - non-GAAP
|
|
$
|
(35.6
|
)
|
|
-21.0
|
%
|
|
$
|
(65.6
|
)
|
-54.4
|
%
|
|
$
|
28.1
|
|
|
8.8
|
%
|
|
|
|
$
|
(101.1
|
)
|
|
-34.8
|
%
|
|
|
$
|
49.7
|
|
|
8.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Net (Loss)/Income per Common Share - Basic
|
|
|
(0.39
|
)
|
|
|
|
|
(0.53
|
)
|
|
|
|
0.06
|
|
|
|
|
|
|
$
|
(0.91
|
)
|
|
|
|
|
$
|
0.08
|
|
|
|
|
Non-GAAP Net (Loss)/Income per Common Share - Basic
|
|
|
(0.21
|
)
|
|
|
|
|
(0.38
|
)
|
|
|
|
0.16
|
|
|
|
|
|
|
$
|
(0.59
|
)
|
|
|
|
|
$
|
0.29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP and Non-GAAP Weighted Average Common Shares - Basic
|
|
|
173.0
|
|
|
|
|
|
172.1
|
|
|
|
|
170.6
|
|
|
|
|
|
|
|
172.6
|
|
|
|
|
|
|
172.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP Net (Loss)/ Income per Common Share - Diluted
|
|
|
(0.39
|
)
|
|
|
|
|
(0.53
|
)
|
|
|
|
0.06
|
|
|
|
|
|
|
$
|
(0.91
|
)
|
|
|
|
|
$
|
0.08
|
|
|
|
|
Non-GAAP Net (Loss)/Income per Common Share - Diluted
|
|
|
(0.21
|
)
|
|
|
|
|
(0.38
|
)
|
|
|
|
0.16
|
|
|
|
|
|
|
$
|
(0.59
|
)
|
|
|
|
|
$
|
0.28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP and Non-GAAP Weighted Average Common Shares - Diluted
|
|
|
173.0
|
|
|
|
|
|
172.1
|
|
|
|
|
174.1
|
|
|
|
|
|
|
|
172.6
|
|
|
|
|
|
|
174.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Reversal of Nextest and Eagle Test purchase accounting inventory
step-up.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) Reversal of previously written down inventory for non-FLEX
products in the Semiconductor Test Division.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) Restructuring and other, net consists of (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended:
|
|
|
|
|
|
|
|
Six Months Ended:
|
|
|
|
|
|
|
|
July 5, 2009
|
|
|
|
April 5, 2009
|
|
|
June 29, 2008
|
|
|
|
|
|
July 5, 2009
|
|
|
|
|
June 29, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Severance
|
|
$
|
15.0
|
|
|
|
|
$
|
16.7
|
|
|
|
$
|
5.5
|
|
|
|
|
|
|
$
|
31.7
|
|
|
|
|
|
$
|
12.6
|
|
|
|
|
Eagle Test Purchase Accounting Adjustment
|
|
|
(0.8
|
)
|
|
|
|
|
(0.7
|
)
|
|
|
|
-
|
|
|
|
|
|
|
|
(1.5
|
)
|
|
|
|
|
|
-
|
|
|
|
|
Facility Related
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
8.3
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
13.0
|
|
|
|
|
Long-Lived Asset Impairment
|
|
|
1.1
|
|
|
|
|
|
-
|
|
|
|
|
0.6
|
|
|
|
|
|
|
|
1.1
|
|
|
|
|
|
|
0.6
|
|
|
|
|
(Gain)/Loss on Sale of Real Estate
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
|
(1.7
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
(1.7
|
)
|
|
|
|
|
|
|
|
$
|
15.3
|
|
|
|
|
$
|
16.0
|
|
|
|
$
|
12.7
|
|
|
|
|
|
|
$
|
31.2
|
|
|
|
|
|
$
|
24.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4) For the quarter and six months ended July 5, 2009, Interest and
Other included a charge to expense deferred debt financing costs as
a result of the repayment and termination of Teradyne's revolving
line of credit and amortization of the GAAP imputed convertible debt
discount. For the quarter ended April 5, 2009 and six months ended
July 5, 2009, Interest and Other included a charge for
other-than-temporary impairment and realized losses on marketable
securities.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5) Profit sharing adjustment for non-GAAP items.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6) Income tax adjustment for non-GAAP items. For the quarter ended
April 5, 2009 and six months ended July 5, 2009, the income tax
adjustment related to a discrete foreign exchange item.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For press releases and other information of interest to investors,
please visit Teradyne's homepage on the World Wide Web at http://www.teradyne.com.
|